Location History:
- Merksem, BE (2014 - 2021)
- Ekeren, BE (2017 - 2023)
Company Filing History:
6 out of 14 
6 out of 238 
1 out of 489 
Years Active: 2014-2023
Title: Innovations and Inventions by Rob Lavigne in Antimicrobial Agents
Introduction
Rob Lavigne, situated in Merksem, Belgium, is an accomplished inventor with a notable portfolio comprising seven patents. His work primarily focuses on antimicrobial agents, particularly targeting Gram-negative bacteria. His innovative contributions are significant in the fields of medicine, food safety, and environmental health.
Latest Patents
Lavigne's latest patents include groundbreaking advancements in antimicrobial agents. One patent details fusion proteins composed of enzymes that degrade the cell walls of Gram-negative bacteria, complemented by a peptide stretch. This invention encompasses pharmaceutical compositions containing these fusion proteins, as well as nucleic acid molecules that code for them. Additionally, it includes vectors and host cells for therapeutic applications, emphasizing their use in treating or preventing Gram-negative bacterial infections.
Another significant patent pertains to polypeptides with specific amino sequences that also aim to combat Gram-negative bacterial infections. This invention expands into various applications including surgery, diagnostics, food safety, and cosmetics, showcasing the versatility and importance of his work in diverse fields.
Career Highlights
Throughout his career, Rob Lavigne has worked with reputable organizations such as Lysando AG and Katholieke Universiteit Leuven (KU Leuven R&D). His experiences at these institutions have significantly influenced his research and invention capabilities, enabling him to develop effective solutions for pressing health and safety challenges.
Collaborations
Collaboration has been a key element in Lavigne’s success. He has worked alongside esteemed colleagues, including Yves Briers and Maarten Walmagh. These partnerships have fostered innovation and facilitated the development of cutting-edge technologies that address critical issues in antimicrobial resistance and bacterial contamination.
Conclusion
Rob Lavigne is a notable figure in the realm of antimicrobial research, with a strong focus on creating innovative solutions for Gram-negative bacterial infections. Through his patents and collaborative efforts, he continues to make significant contributions that impact both human health and food safety, establishing himself as a leading inventor in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.